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Abstract
Introduction: Unlike the quite frequent renal involvement seen in cases of Multiple Myeloma, the
kidney is hardly ever compromised in patients with Waldenström's Macroglobulinemia. Nephrotic
range proteinuria is a very unusual manifestation of renal injury in these patients and when present
it is due to amyloid light-chain deposition most of the times.
Case presentation: A 60-year-old male patient presented to the hospital with nephrotic
syndrome, renal insufficiency, hypertension and lymphadenopathy. The investigations led to the
diagnosis of Waldenström's Macroglobulinemia with associated nephrotic syndrome and chronic
kidney disease due to an unusual form of hypocomplementemic glomerulopathy with
histopathological features similar to those seen in mesangiocapillary glomerulonephritis type III, but
lacking proliferative changes.
Conclusion: We present an unusual case of immunologically-mediated renal damage in a patient
with Waldenström's Macroglobulinemia, leading to non-amyloid nephrotic syndrome and chronic
renal insufficiency.
Introduction
Waldenström's Macroglobulinemia (WM) is a clonal B-
cell lymphoproliferative disorder characterized primarily
by bone marrow infiltration associated with IgM mono-
clonal gammopathy of any concentration in the serum
[1]. It is a distinct clinicopathological entity and its under-
lying pathological diagnosis is Lymphoplasmacytic Lym-
phoma (LPL) [2]. LPL/WM is a rare lymphoid disorder
accounting for only 1 to 2% of all hematologic malignan-
cies [3]. Although several different pathogenic mecha-
nisms that can affect multiple organs have been described
in this disease [3], the kidney is usually spared as com-
pared to Multiple Myeloma and the incidence of both
renal failure and nephrotic syndrome is low [3-5]. This
lesser degree of renal damage has been attributed to the
lower frequency and severity of Bence-Jones proteinuria
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and hypercalcemia. In patients with coexisting WM and
kidney disease, nephrotic-range proteinuria is seen in a
small percentage of cases (7 – 28%) [6,7]. When present,
the most common cause of nephrotic syndrome in these
patients is AL amyloidosis [3,8,9]. Cases of WM with non-
amyloid nephrotic syndrome are anecdotic in the world-
wide literature.
Case presentation
A 60-year old hispanic male presented to the hospital with
a six-month history of slowly progressive bilateral lower
extremity edema and weight gain. His past medical his-
tory was only significant for hypertension. On physical
examination the patient had a blood pressure of 208/109
mmHg, a 4+ bilateral lower extremity edema up to the
thighs, and multiple palpable non-tender axillary and
inguinal lymph nodes, the rest of the exam was otherwise
unremarkable.
The laboratory tests yielded the following relevant values:
hemoglobin 100 g/L, hematocrit 30%, and absolute lym-
phocytosis (6.8 × 103/μL). Urea nitrogen 19.6 mmol/L,
creatinine 477 μmol/L, potassium 5.1 mmol/L, corrected
calcium 2.3 mmol/L, albumin 16 g/L, total protein 40 g/
L, cholesterol 6.72 mmol/L, phosphate 2.32 mmol/L,
intact parathyroid hormone 360 ng/L; high erythrocyte
sedimentation rate (119 mm/hr); microscopic hematuria
(37 rbc/hpf) and nephrotic range proteinuria (10.3 g/24
h); ANA, ANCA, anti-DNAds and anti-GBM negative; low
complement levels (C3 0.15 g/L and C4 0.02 g/L) and
absent cryoglobulins. Normal IgA, low IgG (3.01 g/L) and
increased IgM (9.63 g/L). Negative HBsAg, anti-HCV and
HIV. Serum protein electrophoresis revealed a mono-
clonal spike (0.33 g/dl) and the immunofixation electro-
phoresis showed a monoclonal gammopathy IgM κ.
On retroperitoneal ultrasound the right kidney measured
12.4 cm, the left kidney 12.3 cm, and both showed echo-
genic cortex. A CT scan of the thorax, abdomen and pelvis
reported multiple axillary, pelvic and retroperitoneal lym-
phadenopathy.
Lymph node biopsy
Abundant Congo red negative hyaline-like material was
observed. Small lymphocytes with plasmacytoid appear-
ance were identified. The lymphocytoid population was
CD20+ and CD79a+ representing B cells, and it was nega-
tive for CD3, CD5, CD23, lambda and kappa. IgA, IgG
and IgM immunoreactive cells were observed.
The bone marrow biopsy showed hypercellularity due to
normoblastic erythroid hyperplasia consistent with a sol-
itary large parenchymal lymphoid aggregate of small lym-
phocytes. The immunophenotype was consistent with an
atypical B cell population and plasma cells were present
by flow cytometry.
Kidney biopsy
On light microscopy 11 of 18 glomeruli were globally
sclerosed and more than 50% of the specimen showed
interstitial fibrosis. Marked, global and homogeneous
thickening of the glomerular basement membrane, with
segmental accentuation due to a strongly PAS positive
eosinophilic material was seen and it was Congo red neg-
ative (Figure 1). There were no proliferative or inflamma-
tory changes. Focal nodular collections of the same
material were present in the tubulointerstitial areas and
lymphocytic infiltration was present in the periglomerular
interstitial space. Immunofluorescence showed a diffuse
global, granular to homogenous deposition of IgG (3+),
IgA (3+), IgM (2+), C3 (3+), C4 (3+), C1q (3+), albumin
(3+), kappa (3+), lambda (3+) and fibrinogen (1+)
involving principally the basement membranes (Figure
2). Focal homogenous deposition of the same immunore-
actants with similar fluorescence intensity was seen in the
tubulointerstitial areas. No vascular fluorescence was
apparent. Finally, electron microscopy showed extensive
glomerular sclerosis and basement membrane thickening
with significant reduction of the capillary lumen in the
remaining glomeruli (Figure 3). There were numerous
electron-dense deposits present in both mesangium and
Light Microscopy Figure 1
Light Microscopy. There is marked, global, homogeneous, 
eosinophilic thickening of the glomerular basement mem-
brane with segmental accentuation. Homogeneous, eosi-
nophilic globules are seen in the lumen of occasional capillary 
loops. The capillary lumina appear reduced in diameter but 
no inflammatory or proliferative changes are observed. The 
periglomerular interstitial space shows lymphocytic infiltra-
tion. Focal interstitial deposition of homogeneous eosi-
nophilic material is present in the right upper corner of the 
picture (H&E × 400).Cases Journal 2008, 1:333 http://www.casesjournal.com/content/1/1/333
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glomerular membranes, but principally in the latter.
Some of them clearly showed a subendothelial or subepi-
thelial location (Figure 4). The deposits did not exhibit an
organized substructure (microtubular or fibrillary). No
fibrin thrombi were found. The interstitial areas were
expanded due to the presence of mononuclear inflamma-
tory cells (monocytes and plasma cells), increased colla-
gen, and electron dense deposits similar to those
identified in glomeruli.
The patient was started on β-blocker and calcium channel
blocker therapy for blood pressure control, Erythropoietin
for anemia treatment, phosphate binder and vitamin D
analog for mineral and bone disorder management, loop
diuretic for volume overload treatment and subcutaneous
Heparin for thromboembolic prophylaxis; no renal
replacement therapy was warranted during his hospital
stay. The renal function worsened over the first days of his
hospitalization with a peak creatinine of 583 μmol/L,
hence, in light of the laboratory and preliminary his-
topathologic results, a trial of steroid therapy with Pred-
nisone 1 mg/kg/day was started at that moment in order
to avoid further kidney damage with a partial positive
response over the following days (decrease in creatinine
to 424 μmol/L). Further immunosuppressive therapy was
considered at that point, unfortunately a post-surgical
infection developed following the left inguinal lymph
node biopsy leading to septic shock, and in spite of
aggressive management with broad-spectrum antibiotic
therapy, respiratory support, fluids and vasopressors the
patient expired 22 days after his hospital admission. The
autopsy report did not add any pertinent information to
the case.
Discussion
The diagnosis of Waldenström's Macroglobulinemia has
always been challenging and has evolved from the origi-
nal description of a clinical syndrome to the more recent
designation as a distinct clinicopathologic entity [2].
Although significant advances have been made regarding
lymphoma classification, there are no disease-defining
morphological, immunophenotipic or chromosomal
abnormalities specific for WM, a diagnosis can therefore
be made on the basis of clinical and pathological findings
[1]. We present a patient who was found to have an IgM
monoclonal gammopathy in the serum associated with
lymph node and bone marrow infiltration by a small B-
cell population with plasmacytic differentiation. The
lymph node biopsy revealed the presence of plasmacytoid
cells that expressed an immunophenotypic profile con-
Immunofluorescence Figure 2
Immunofluorescence. Global granular and homogeneous 
deposition of IgG along the glomerular basement membrane. 
Notice the presence of IgG containing globules in rare capil-
lary loops. They seem to correspond to the eosinophilic 
globules seen by light microscopy and large electron dense 
deposits detected by electron microscopy (FITC labeled anti-
IgG × 400).
Electron Microscopy Figure 3
Electron Microscopy. There is marked thickening of the 
glomerular basement membrane due to the presence of 
numerous electron dense deposits located at different levels. 
The deposits vary in size, tend to be spherical in shape and 
blend together. Under higher magnifications, they did not 
exhibit a fibrillary or micro-tubular substructure. Notice a 
thin subendothelial layer of duplicated basement membrane, 
also containing electron dense deposits, with cellular inter-
position. The capillary lumen appears significantly reduced in 
diameter. Also notice electron dense deposits present in the 
basement membrane of Bowman's capsule on the right upper 
corner (Uranyl acetate & lead citrate × 35,000).Cases Journal 2008, 1:333 http://www.casesjournal.com/content/1/1/333
Page 4 of 5
(page number not for citation purposes)
sistent with WM according to the definition criteria [1].
The pattern of infiltration in the bone marrow was not
intertrabecullar as defined by the diagnostic criteria; nev-
ertheless, although this characteristic is considered to be
helpful supporting evidence it is not the only described
infiltrative pattern in cases of WM.
Renal involvement in WM is usually expressed as mild
non-selective proteinuria and microscopic hematuria [9].
The renal compromise in our patient presented as micro-
scopic hematuria, nephrotic syndrome and chronic renal
insufficiency. The nephrotic syndrome work-up was only
positive for significant hypocompletemia suggesting an
immunologically-mediated disorder with serum comple-
ment consumption. Amyloidosis and cryoglobulinemia
were ruled out. As mentioned above, nephrotic syndrome
is a rare manifestation of kidney involvement in patients
with WM; in a recent case series study only 2 out of 7
patients with coexisting WM and kidney disease presented
with nephrotic-range proteinuria [7]. When present, this
syndrome is usually caused by amyloidosis [3,8,9]; other
very unusual causes include cryoglobulinemia [10,11],
minimal change disease [12,13], intracapillary mono-
clonal deposit disease [7,14] and immunocomplex-medi-
ated glomerulonephritis [15,16].
The usual renal histopathologic finding in WM is the pres-
ence of amorphous PAS-positive subendothelial deposits
that usually occlude the capillary lumen and by electron
microscopy consist of non-amyloid fibrillary material [6].
Immunofluorescence demonstrating the presence of IgM
within the glomeruli is the most commonly described pat-
tern [3,9,10,14,17].
The histopathologic findings in our patient are similar to
those originally described in MPGN type III (but lacking
proliferative changes) and also often seen in proliferative
lupus nephritis, but they differ from the typical pattern of
renal involvement in WM in several features, firstly the
absence of thrombotic deposits in the capillary lumen,
secondly no fibrillary material was identified in the elec-
tron microscopy, thirdly the presence of glomerular
deposits consisting of multiple immunoglobulins and
complement factors instead of IgM alone, and finally the
simultaneous involvement of the tunulointerstitial areas.
These findings can be attributed to an immunologically
mediated mechanism with deposition of immune com-
plex and complement factors. Furthermore, the evidence
of hypocomplementemia correlates well with this sug-
gested renal insult. Similar glomerular immunofluores-
cence characteristics have been described in only two
previous reported cases however neither had renal impair-
ment [15,16]. Even though the link between hematologic
malignancies and glomerulonephritis has been well doc-
umented, the underlying pathogenesis in cases of WM is
still unclear but it can be explained by the known intrinsic
autoantibody activity of IgM [3].
In summary, we present a rare case of immunologically-
mediated glomerulopathy associated with tubulointersti-
tial damage, leading to nephrotic syndrome and chronic
kidney disease in a patient with LPL/WM.
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Electron Microscopy Figure 4
Electron Microscopy. This field illustrates a large suben-
dothelial and several, much smaller, subepithelial electron 
dense deposits. This pattern is similar to that originally 
described in MPGN type III and also often seen in prolifera-
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segment also contains electron dense deposits. Occasionally 
giant, subendothelial, globular electron dense deposits 
reduced the capillary loop to a pin-point lumen. Probably 
they correspond to the globules seen by light and fluores-
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